A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants

Inclusion Criteria: * Healthy male subjects or healthy female between 18 and 55 years of age (inclusive) at the time of Screening. * Body mass index between 18 and 30 kg/m2 (inclusive) at the time of Screening. * Females of nonchildbearing potential Exclusion Criteria: * History or evidence, at Screening or Check-in, of clinically significant disorder, condition, or disease not otherwise excluded that, in the opinion of the Investigator (or designee), would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion. * Inability to swallow oral medication or history of malabsorption syndrome. * Poor peripheral venous access. * History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance, unless approved by the Investigator (or designee) and in consultation with the Sponsor.